Growth and endocrine function in thalassemia major in childhood and adolescence

Journal of Endocrinological Investigation

Volumn 33, Issue 1, 2010, Pages 61-68

  Delvecchio, M ^a   Cavallo, L ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Glucose homeostasis; Growth; Pubertal development; Thalassemia major; Thyroid

Indexed keywords

CHORIONIC GONADOTROPIN; DEFERIPRONE; DEFEROXAMINE; ETHINYLESTRADIOL; FOLLITROPIN; GLIBENCLAMIDE; PROGESTERONE; RECOMBINANT GROWTH HORMONE; TESTOSTERONE;

AUTOIMMUNE THYROIDITIS; CHELATION THERAPY; CHILD GROWTH; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; ENDOCRINE FUNCTION; GLUCOSE TOLERANCE; GROWTH ACCELERATION; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPOGONADISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LOW DRUG DOSE; PANCREAS ISLET BETA CELL; PUBERTY; REVIEW; SHORT STATURE; THALASSEMIA MAJOR; THYROID DISEASE;

EID: 77950537101     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346551     Document Type: Review

References (123)

1. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC; Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006, 19: 471-480
2. Constantoulakis M, Panagopoulos G, Augoustaki O. Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients. Clin Pediatr (Phila) 1975, 14: 355-7/362-8.
3. Cavallo L, De Mattia D, Giobbe T, et al. Growth in homozygous β-thalassemia patients. In: Cavallo L, Job JC, New MI, eds. Growth Disorders: the State of the art. Serono Symposia No. 81. Rome: Raven Press. 1991, 47-54.
4. Garcia-Mayor RV, Andrade Olivie A, Fernández Catalina P, Castro M, Rego Iraeta A, Reparaz A. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm Res 1993, 40: 189-193
5. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK. Short stature in homozygous β-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol (Oxf) 1995, 42: 587-592
6. Pérignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R. Growth and endocrine function in major thalassemia. Arch Fr Pediatr 1993, 50: 657-663
7. Theodoridis C, Ladis V, Papatheodorou A, et al. Growth and management of short stature in thalassaemia major. J Pediatr Endocrinol Metab 1998, 11 (Suppl 3): 835-844
8. Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 2003, 16 (Suppl 2): 259-266
9. Low L. Growth of children with β-thalassemia major. Indian J Pediatr 2005, 72: 159-164
10. Shalitin S, Carmi D, Weintrob N, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol 2005, 74: 93-100.
11. De Virgiliis S, Congia M, Frau F, et al. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 1988, 113: 661-669
12. De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. Clin Endocrinol (Oxf) 1994, 40: 791-798
13. De Sanctis V. Growth and puberty and its management in thalassemia. Horm Res 2002, 58 (Suppl 1): 72-79
14. Arcasoy A, Cavdar A, Cin S, et al. Effects of zinc supplementation on linear growth in beta-thalassemia (a new approach). Am J Hematol 1987, 24: 127-136
15. Eshghi P, Alavi S, Ghavami S, Rashidi A. Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors. J Pediatr Hematol Oncol 2007, 29: 5-8.
16. Mehdizadeh M, Zamani G, Tabatabaee S. Zinc status in patients with major beta-thalassemia. Pediatr Hematol Oncol 2008, 25: 49-54.
17. Filosa A, Di Maio S, Baron I, Esposito G, Galati MG. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty. Acta Paediatr 2000, 89: 1295-1301
18. Caruso-Nicoletti M, De Sanctis V, Raiola G, Skordis N, Mancuso M, Coco M, Wonke B. No difference in pubertal growth and final height between treated hypogonadal and non-hypogonadal thalassemic patients. Horm Res 2004, 62: 17-22.
19. Cavallo L, Gurrado R, Gallo F, Zacchino C, De Mattia D, Tatò L. Growth deficiency in polytransfused β-thalassemia patients is not growth hormone dependent. Clin Endocrinol 1997, 46: 701-706
20. Caruso-Nicoletti M, De Sanctis V, Capra M, et al. Short stature and body proportion in thalassaemia. J Pediatr Endocrinol Metab 1998, 11 (Suppl 3): 811-816
21. Low CK, Kwan YW, Cheung PT, et al. The effect of platyspondyly and pubertal growth spurt on the stature of patients with beta-thalassaemia major. Chin Med J (Engl) 1998, 111: 731-735
22. Skordis N, Michaelidou M, Savva SC, et al. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol 2006, 77: 150-156
23. Shehadeh N, Hazani A, Rudolf MC, Peleg I, Benderly A, Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand 1990, 79: 790-795
24. Chatterjee R, Katz M, Cox T, Bantock H. Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test. Eur J Pediatr 1993, 152: 721-726
25. Katzos G, Harsoulis F, Papadopoulou M, Athanasiou M, Sava K. Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major. Eur J Pediatr 1995, 154: 445-449
26. Roth C, Pekrun A, Bartz M, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr 1997, 156: 777-783
27. Soliman AT, elZalabany MM, Mazloum Y, et al. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth. J Trop Pediatr 1999, 45: 327-337
28. Karydis I, Karagiorga-Lagana M, Nounopoulos C, Tolis G. Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major. J Pediatr Endocrinol Metab 2004, 17: 17-25.
29. McIntosh N. Endocrinopathy in thalassaemia major. Arch Dis Child 1976, 51: 195-201.
30. Vannasaeng S, Ploybutr S, Visutkul P, Tandhanand S, Suwanik R, Wasi P. Endocrine function in thalassaemia. Clin Endocrinol (Oxf) 1981, 14: 165-173
31. Masala A, Meloni T, Gallisai D, et al. Endocrine functioning in multitransfused prepubertal patients with homozygous beta-thalassemia. J Clin Endocrinol Metab 1984, 58: 667-670
32. Leger J, Girot R, Crosnier H, Postel-Vinay MC, Rappaport R. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J Clin Endocrinol Metab 1989, 69: 453-456
33. Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism 1998, 47: 541-548
34. Soliman AT, El Banna N, Ansari BM. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia. Eur J Endocrinol 1998, 138: 394-400.
35. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 2000, 13: 651-656
36. Chrysis DC, Alexandrides TK, Koromantzou E, et al. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia. Clin Endocrinol (Oxf) 2001, 54: 253-259
37. Aydinok Y, Darcan S, Polat A, et al. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr 2002, 48: 50-54
38. Karamifar H, Karimi M, Amirhakimi G, Sharbatialaei M, De Sanctis V. Reduced insulin growth factor I concentrations in iron-overloaded beta thalassaemic patients with normal growth hormone secretion and liver function. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 256-258
39. De Sanctis V, Eleftheriou A, Malaventura C; Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 249-255
40. Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Arch Iran Med 2006, 9: 329-334
41. Pintor C, Cella SG, Manso P, et al. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major. J Clin Endocrinol Metab 1986, 62: 263-267
42. Leheup BP, Cisternino M, Bozzola M, et al. Growth hormone response following growth hormone releasing hormone injection in thalassemia major: influence of pubertal development. J Endocrinol Invest 1991, 14: 37-40.
43. Danesi L, Scacchi M, De Martin M, et al. Evaluation of hypothalamic-pituitary function in patients with thalassemia major. J Endocrinol Invest 1992, 15: 177-184
44. DeLuca G, Maggiolini M, Bria M, et al. GH secretion in thalassemia patients with short stature. Horm Res 1995, 44: 158-163
45. Postel-Vinay MC, Girat R, Leger J, et al. No evidence for a defect in growth hormone binding to liver membranes in thalassemia major. J Clin Endocrinol Metab 1989, 68: 94-98
46. Saenger P, Schwartz E, Markenson AL, et al. Depressed serum somatomedin activity in beta-thalassemia. J Pediatr 1980, 96: 214-218
47. Werther GA, Matthews RN, Burger HG, Herington AC. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. J Clin Endocrinol Metab 1981, 53: 806-809
48. Lasco A, Morabito N, Gaudio A, et al. Osteoporosis and beta-thalassemia major role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 2002, 25: 338-344
49. Low LCK, Postel-Vinay MC, Kwan EY, Cheung PT. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Clin Endocrinol (Oxf) 1998, 48: 641-646
50. Caruso-Nicoletti M. Epidemiological assessment of GH deficiency in Thalassemic patients. J Endocrinol Invest 2006, 29 (Suppl 5): 105-109
51. Scacchi M, Danesi L, De Martin M, et al. Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion. Clin Endocrinol (Oxf) 1991, 35: 335-339
52. Low LC, Kwan EY, Lim YJ, Lee AC, Tam CF, Lam KS. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency. Clin Endocrinol (Oxf) 1995, 42: 359-363
53. De Sanctis V, Urso L. Growth and thalassemia. Minerva Pediatr 1997, 49: 121-128
54. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab 1997, 10: 175-184
55. Cavallo L, Gurrado R, Zecchino C, et al. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency. J Pediatr Endocrinol Metab 1998, 11 (Suppl 3): 845-849
56. Arcasoy A, Ocal G, Kemahli S, et al. Recombinant human growth hormone treatment in children with thalassemia major. Pediatr Int 1999, 41: 655-661
57. Katzos G, Papakostantinou-Athanasiadou E, Athanasiou-Metaxa M, Harsoulis F. Growth hormone treatment in short children with beta-thalassemia major. J Pediatr Endocrinol Metab 2000, 13: 163-170
58. Sartorio A, Conte G, Conti A, et al. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major. J Endocrinol Invest 2000, 23: 356-361
59. Kwan EY, Tam SC, Cheung PT, Low LC. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with beta-thalassemia major. J Pediatr Endocrinol Metab 2000, 13: 545-552
60. Cavallo L, Acquafredda A Zecchino C, et al. Recombinant growth hormone treatment in short patients with thalassemia major: results after 24 and 36 months. J Pediatr Endocrinol Metab 2001, 14: 1133-1137
61. Masala A, Atzeni MM, Alagna S, et al. Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy. J Endocrinol Invest 2003, 26: 623-628
62. Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol 2003, 82: 637-640
63. Cavallo L, De Sanctis V, Cisternino M, et al. Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone. J Endocrinol Invest 2005, 28: 363-366
64. Fung EB, Harmatz PR, Lee PD, et al; Multi-Centre Study of Iron Overload Research Group. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006, 135: 574-582
65. Allegra A, Capra M, Cuccia L, et al. Hypogonadism in beta-thalassemic adolescents: a characteristic pituitary-gonadal impairment The ineffectiveness of long-term iron chelation therapy. Gynecol Endocrinol 1990, 4: 181-191
66. Soliman AT, elZalabany MM, Ragab M, et al. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. J Trop Pediatr 2000, 46: 79-85.
67. Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR. Hypothalamic-pituitary- gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet 2005, 90: 44-47
68. Al-Rimawi HS, Jallad MF, Amarin ZO, Al Sakaan R. Pubertal evaluation of adolescent boys with beta-thalassemia major and delayed puberty. Fertil Steril 2006, 86: 886-890
69. Soliman AT, Nasr I, Thabet A, Rizk MM, El Matary W. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major. Metabolism 2005, 54: 15-23.
70. Oerter KE, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993, 76: 357-361
71. Bericovitch M, Bistritzer T, Milone SD, Perlman K, Kucharczyk W, Olivieri NF. Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab 2000, 13: 179-184
72. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol 2007, 62: 138-142
73. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major. N Engl J Med 1990, 323: 713-719
74. Chatterjee R, Katz M. Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clin Endocrinol (Oxf) 2000, 53: 33-42.
75. Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol 1997, 59: 76-81.
76. Chern JP, Lin KH, Tsai WY, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia. J Pediatr Hematol Oncol 2003, 25: 880-884
77. Skordis N, Goumi M, Kanaris C, et al. The impact of iron overload and genotype on gonadal function in women with thalassaemia major. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 292-295
78. Pomarède R, Girat R, Constant S, Rappaport R. Effect of hematologic treatment on the growth and puberty of children with thalassemia major. Arch Fr Pediatr 1984, 41: 255-259
79. Wang C, Tso SC, Todd D. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab 1989, 68: 511-516
80. Skordis N, Petrikkos L, Toumba M, et al. Update on fertility in thalassaemia major. Pediatr Endocrinol Rev 2004, 2 (Supp 2): 296-302.
81. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf) 1995, 42: 581-586
82. Arrigo T, Crisafulli G, Meo A, et al. Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major. J Pediatr Endocrinol Metab 1998, 11 (Suppl 3): 863-866
83. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR; Thalassemia Clinical Research Network. Complications of beta-thalassemia major in North America. Blood 2004, 104: 34-39
84. Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 285-291
85. Kattamis C, Ladis V, Tsoussis D, Kaloumenou I, Theodoridis C. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 267-271
86. Suvama J, Ingle H, Deshmukh CT. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Indian Pediatr 2006, 43: 393-400.
87. Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with Thalassaemia Major. Pediatr Endocrinol Rev 2007, 5: 642-648
88. Livadas DP, Economou E, Sofroniadou K, et al. A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme. Clin Endocrinol (Oxf) 1987, 27: 485-490
89. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F. Insulin dependent diabetes in thalassaemia. Arch Dis Child 1988, 63: 58-62.
90. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994, 331: 567-573
91. Chern JP, Lin KH, Lu MY, et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care 2001, 24: 850-854
92. Cario H, Holl RW, Debatin KM, Kohne E. Disproportionately elevated fasting proinsulin levels in normoglycemic patients with thalassemia major are correlated to the degree of iron overload. Horm Res 2003, 59: 73-78
93. Zuppinger K, Molinari B, Hirt A, et al. Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload. Helv Paediatr Acta 1979, 34: 197-207.
94. Sougleri M, Labropoulou-Karatza C, Paraskevopoulou P, Fragopanagou H, Alexandrides T. Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major. Eur J Gastroenterol Hepatol 2001, 13: 1195-1199
95. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes 2004, 5: 126-132
96. Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 282-284
97. Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in beta-thalassemia major. Metabolism 1977, 26: 43-52.
98. el-Hazmi MA, al-Swailem A, al-Fawaz I, Warsey AS, al-Swailem A. Diabetes mellitus in children suffering from beta-thalassaemia. J Trap Pediatr 1994, 40: 261-266
99. Cavallo L, Trentadue RF, Liuzzi S, et al. A transverse and longitudinal study of pancreatic function and glucose tolerance in thalassemic patients. In: Endocrine disorders in thalassemia. Andò S, Brancati C eds. Berlin: Springer Verlag. 1995, 153-155
100. Flynn DM, Faimey A, Jackson D, Clayton BE. Hormonal changes in thalassaemia major. Arch Dis Child 1976, 51: 828-836
101. Merkel PA, Simonson DC, Amiel SA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988, 318: 809-814
102. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab 1993, 77: 478-483
103. Cavallo-Perin P, Pacini G, Cerutti F, et al. Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia. Metabolism 1995, 44: 281-286
104. Pappas S, Donohue SM, Denver AE, Mohamed-Ali V, Goubet S, Yudkin JS. Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction. Metabolism 1996, 45: 652-657
105. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 2003, 162: 139-146
106. Angelopoulos NG, Zervas A, Livadas S, et al. Reduced insulin secretion in normoglycaemic patients with beta-thalassaemia major. Diabet Med 2006, 23: 1327-1331
107. Rodacki M, Pereira JR, Nabuco de Oliveira AM, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract 2007, 78: 259-262
108. Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol 2006, 134: 438-444
109. Christoforidis A, Perifanis V, Tsatra I, Vlachaki E, Athanassiou-Metaxa M. Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy. Diabetes Res Clin Pract 2007, 76: 6-11.
110. Jones TW, Boulware SD, Caprio S, et al. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. Pediatr Res 1993, 33: 497-500.
111. Ladis V, Theodorides C, Palamidou F, Frissiras S, Berdousi H, Kattamis C. Glucose disturbances and regulation with glibenclamide in thalassemia. J Pediatr Endocrinol Metab 1998, 11 (Suppl 3): 871-878
112. Ladis V, Theodorides C, Palamidou F, Frissiras S, Berdousi H, Kattamis C. Regulation of glucose disturbances with glibenclamide in patients with thalassemia. Ann N Y Acad Sci 1998, 850: 471-474
113. Mangiagli A, Campisi S, De Sanctis V, et al; Study Group of the Italian Pediatric and Diabetes Soceity (SIEDP) on Endocrine Complications in Non-Endocrine Disease. Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 272-275
114. Cavallo L, Licci D, Acquafredda A, et al. Endocrine involvement in children with beta-thalassaemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol (Copenh) 1984, 107: 49-53.
115. Jain M, Sinha RS, Chellani H, Anand NK. Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr 1995, 32: 213-219
116. Zervas A, Katopodi A Protonotariou A, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002, 12: 151-154
117. Cavallo L, Mautone A, Altomare M, Licciulli M, Pascazio A, Schettini F. Pituitary-thyroid function in children with beta-thalassaemia major. Acta Endocrinol (Copenh) 1981, 96: 59-64.
118. Phenekos C, Karamerou A, Pipis P, et al. Thyroid function in patients with homozygous beta-thalassaemia. Clin Endocrinol (Oxf) 1984, 20: 445-450
119. Magro S, Puzzonia P, Consarino C, et al. Hypothyroidism in patients with thalassemia syndromes. Acta Haematol 1990, 84: 72-76
120. Agarwal MB, Shah S, Vishwanathan C, et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr 1992, 29: 997-1002.
121. Landau H, Matoth I, Landau-Cordova Z, Goldfarb A, Rachmilewitz EA, Glaser B. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 1993, 38: 55-61.
122. Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab 2006, 19: 1397-1404
123. Pitrolo L, Malizia G, Lo Pinto C, Malizia V, Capra M. Ultrasound thyroid evaluation in thalassemic patients: correlation between the aspects of thyroidal stroma and function. Pediatr Endocrinol Rev 2004, 2 (Suppl 2): 313-315